Seronegative rheumatoid arthritis

RHEUMA_SERONEG

rheumatoid arthritis: A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M06.0 Hospital discharge: ICD-9 — 7140B Cause of death: ICD-10 — M06.0 Cause of death: ICD-9 — 7140B 2 out of 7 registries used, show all original rules.	5128
4. Check minimum number of events None	5128
5. Include endpoints None	5128
6. Filter based on genotype QC (FinnGen only)	5128

Control definitions (FinnGen only)

Control exclude: RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: M06
Name in latin: Arthritis rheumatoides seronegativa

NAME	RHEUMA_SERONEG
CONTROL_EXCLUDE	RHEUMA_ENDPOINTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M060
HD_ICD_9	7140B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M060
COD_ICD_9	7140B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Seronegative rheumatoid arthritis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	32653	23007	9442
Only index persons	27640	19750	7890
Unadjusted period prevalence (%)
Whole population	0.54	0.66	0.26
Only index persons	0.60	0.73	0.30
Median age at first event (years)
Whole population	58.77	58.03	60.42
Only index persons	56.74	56.04	58.50

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5128	3628	1500
Unadjusted period prevalence (%)	1.07	1.24	0.66
Median age at first event (years)	54.80	52.94	59.30

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4686: Matched controls
46861

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

12.0

323.0

3878

13399

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

73.7

323.0

588

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

10.7

323.0

1075

1271

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.4

323.0

2844

10361

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4503599627370496.0

323.0

4416

M13.9

ICD-10 Finland

Arthritis, unspecified

59.6

323.0

1404

334

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

284.5

323.0

367

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

469.9

323.0

1834

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

+∞

323.0

578

L04AB01

ATC

etanercept; parenteral

1447.6

323.0

516

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

161.8

323.0

345

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2457.4

323.0

2143

L04AB04

ATC

adalimumab; parenteral

119.6

323.0

483

L04AA13

ATC

leflunomide; oral

866.8

323.0

1176

M17.1

ICD-10 Finland

Other primary gonarthrosis

15.7

323.0

1037

834

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

137.6

323.0

2198

299

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

13.2

323.0

933

867

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

344.2

323.0

1468

A07EC01

ATC

sulfasalazine; oral, rectal

186.5

323.0

2982

433

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

323.0

419

TNG10

NOMESCO Finland

Puncture of knee

598.7

323.0

335

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1709.0

323.0

1060

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

139.9

323.0

489

L88

ICPC

Rheumatoid/seropositive arthritis

276.1

323.0

1370

NH3EA

NOMESCO Finland

Feet X-ray examination with load

42.6

323.0

413

106

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2046.8

323.0

674

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

60.8

323.0

637

121

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

920.3

323.0

4207

452

H02AB07

ATC

prednisone; oral

5.3

323.0

1347

3310

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

126.6

323.0

1909

253

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2148.7

323.0

988

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

15.5

323.0

1362

1204

M01CB01

ATC

sodium aurothiomalate; parenteral

2551.4

323.0

692

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1610.4

323.0

688

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

286.4

323.0

3403

426

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

594.8

323.0

333

P01BA02

ATC

hydroxychloroquine; oral

290.1

323.0

3253

365

M16.1

ICD-10 Finland

Other primary coxarthrosis

24.2

320.7

466

213

M01CB03

ATC

auranofin; oral

474.5

315.5

312

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

10.5

297.0

614

666

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

291.9

2535

12793

NF1AA

NOMESCO Finland

Hip X-ray examination

8.5

272.1

636

850

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

321.8

269.3

271

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

240.5

266.2

272

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

192.4

262.4

272

M06

ICD-10 Finland

Other rheumatoid arthritis

874.7

255.6

249

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

658.0

254.9

250

L04AA01

ATC

[U] ciclosporin; systemic

32.7

248.9

332

109

M01AH01

ATC

celecoxib; oral (coxibs)

3.8

248.6

1255

4087

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

11.9

247.7

475

439

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

193.3

247.0

256

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

27.0

246.5

346

138

M25.5

ICD-10 Finland

Pain in joint

3.3

246.2

1628

6552

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

38.4

246.1

316

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

30.9

241.0

326

113

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2317.9

240.5

231

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

21.5

238.6

359

180

M13.0

ICD-10 Finland

Polyarthritis, unspecified

71.2

234.2

269

M01AH05

ATC

etoricoxib; oral

2.8

233.2

2957

17933

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

6.0

231.4

697

1323

WX320

NOMESCO Finland

Spinalanesthesy

3.6

230.2

1257

4330

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

45.9

220.8

273

M01AC06

ATC

meloxicam; systemic, rectal

2.8

219.7

2127

10820

N02AX02

ATC

tramadol; systemic, rectal

2.7

218.8

2217

11586

L04AX01

ATC

azathioprine; systemic

9.5

218.5

473

547

NG1DA

NOMESCO Finland

X-ray of knees

59.0

217.4

257

L04AB06

ATC

golimumab; parenteral

329.4

216.6

218

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

734.5

215.5

211

M45

ICD-10 Finland

Ankylosing spondylitis

120.3

212.3

229

M35.3

ICD-10 Finland

Polymyalgia rheumatica

18.0

210.6

337

201

M05BA04

ATC

alendronic acid; oral

4.6

198.0

772

1938

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

72.8

188.7

216

H02AB04

ATC

methylprednisolone; systemic

3.4

182.7

1032

3566

NDG30

NOMESCO Finland

Fusion of wrist, total

213.9

179.5

185

L04AA24

ATC

abatacept; parenteral

+∞

175.1

167

XX9XE

NOMESCO Finland

Other ultrasound examination

85.3

174.8

196

L04AA11

ATC

[U] etanercept; parenteral

+∞

174.0

166

M01AH02

ATC

rofecoxib; oral

3.5

169.1

897

2932

L04AA17

ATC

[U] adalimumab; parenteral

+∞

165.6

158

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

16.9

162.9

266

166

NDL52

NOMESCO Finland

Tenosynovectomy of hand

52.1

161.6

195

B01AB05

ATC

enoxaparin; parenteral

2.6

161.2

1524

7302

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

159.7

2259

13356

A02BC02

ATC

pantoprazole; systemic

2.4

159.6

3241

22836

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

86.6

156.4

175

ZX140

NOMESCO Finland

Intra articular

89.3

154.3

172

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

1549.2

151.9

147

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.2

151.8

645

1730

M01AE02

ATC

naproxen; oral, rectal

2.3

151.3

2788

18502

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

5.0

151.1

528

1163

WZA10

NOMESCO Finland

Long statement of health and health related matters

20.2

151.0

231

120

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

18.0

150.6

240

140

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

56.0

149.4

178

L04AB05

ATC

certolizumab pegol; parenteral

+∞

148.7

142

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

64.1

148.4

173

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

52.5

146.9

177

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

6.9

146.3

386

600

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

371.0

144.7

145

M07.3

ICD-10 Finland

Other psoriatic arthropathies

215.2

141.7

146

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.3

140.7

1916

10907

L40.5

ICD-10 Finland

Arthropathic psoriasis

37.6

140.6

181

N02BE01

ATC

paracetamol; systemic, rectal

2.8

140.4

4101

33480

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.7

138.1

505

1163

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

103.3

136.9

150

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

14.4

135.7

236

172

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.5

133.3

697

2217

NF1DA

NOMESCO Finland

X-ray of hips

26.3

131.5

185

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

229.8

130.6

134

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

34.6

127.4

167

L04AC07

ATC

tocilizumab; parenteral

+∞

125.6

120

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

7.6

125.4

309

433

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

9.2

124.9

272

312

B01AF01

ATC

rivaroxaban; oral

3.9

124.1

562

1581

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

+∞

123.5

118

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

123.2

1725

9777

WX111

NOMESCO Finland

Local infiltration anesthesia

215.7

122.3

126

M01AX17

ATC

nimesulide; oral

2.4

122.1

1338

6737

L15

ICPC

Knee symptom/complaint

2.7

120.1

953

4014

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

54.2

118.6

142

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

4.1

117.9

498

1313

S18

ICPC

Laceration/cut

2.1

117.7

2007

12332

M01AB55

ATC

diclofenac, combinations; oral

4.1

117.0

498

1322

291

Kela drug reimbursment

Tofacitinib

1156.4

116.2

113

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

49.0

113.3

138

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.4

113.1

365

728

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.8

112.2

298

464

N03AX16

ATC

pregabalin; oral

2.4

111.6

1182

5805

R4120

NOMESCO Finland

Occupational therapy

4.2

110.6

459

1188

B01AX06

ATC

[U] rivaroxaban; oral

45.1

109.9

136

M17.5

ICD-10 Finland

Other secondary gonarthrosis

65.2

109.4

127

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.7

109.1

879

3711

L04AA29

ATC

tofacitinib; oral

162.3

105.7

111

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.8

105.1

371

816

9522

FHL

Synovectomy

269.1

103.2

105

SPAT1153

SPAT

Removal of sutures

2.1

100.6

1544

8920

ZX120

NOMESCO Finland

Intravenous

3.1

100.2

605

2112

SPAT1202

SPAT

Intra-articular injection

7.5

98.1

242

338

TQW40

NOMESCO Finland

Remowal of suture of skin

3.5

97.7

494

1510

M05BA07

ATC

risedronic acid; oral

5.3

96.9

315

631

H02AB08

ATC

triamcinolone; systemic

43.9

96.6

120

ZXA00

NOMESCO Finland

Right side

2.1

96.3

1334

7345

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

38.2

96.2

123

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

4.7

96.1

347

780

J01DB01

ATC

cefalexin; oral

2.1

95.5

3762

30873

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

22.0

95.2

141

ZZH31

NOMESCO Finland

Bone allograft, small pieces

36.8

94.6

122

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.1

94.2

272

472

J01FF01

ATC

clindamycin; systemic

2.1

93.9

1343

7483

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

+∞

93.0

L01CB

ATC

Podophyllotoxin derivatives

+∞

92.0

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

6.3

91.6

257

430

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.7

91.4

715

2939

3006

Kela drug reimbursment

Baricitinib

+∞

90.9

NHG22

NOMESCO Finland

Fusion of subtalar joint

28.9

90.7

124

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

895.2

90.0

L90

ICPC

Osteoarthrosis of knee

5.6

89.9

277

521

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

79.5

89.5

101

L20

ICPC

Joint symptom/complaint NOS

5.7

88.7

267

488

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

7.1

88.3

226

333

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

440.7

87.4

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

4.0

86.0

371

988

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

+∞

85.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

85.5

2093

14186

NG2AA

NOMESCO Finland

Patella X-ray examination

18.8

84.8

132

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

54.3

84.6

101

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

83.9

1353

7849

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

83.9

1810

11710

293

Kela drug reimbursment

Baricitinib

+∞

83.6

9256

FHL

Synovectomy (knee 9311)

286.5

82.9

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

81.5

L04AA37

ATC

baricitinib; oral

+∞

81.5

L28

ICPC

Limited function/disability (L)

2.4

81.1

769

3498

N03AX12

ATC

gabapentin; oral

2.5

81.0

740

3301

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

29.8

79.8

108

L04AD01

ATC

ciclosporin; systemic

8.6

79.5

178

213

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

9.1

78.6

170

192

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

44.9

78.6

WX204

NOMESCO Finland

Axillary plexus blockaced

5.4

78.4

248

480

M79.6

ICD-10 Finland

Pain in limb

1.9

78.2

1588

9989

3005

Kela drug reimbursment

Tofacitinib

122.1

78.1

M13.8

ICD-10 Finland

Other specified arthritis

25.3

77.0

109

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

5.4

76.6

244

476

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

137.3

76.2

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

57.3

76.1

RT272

NOMESCO Finland

92.8

74.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

73.3

1372

8335

ZXA05

NOMESCO Finland

Left side

2.0

72.7

1177

6766

M48.0

ICD-10 Finland

Spinal stenosis

2.6

72.6

581

2398

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

3.2

72.4

414

1376

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

3.1

72.0

435

1502

L13

ICPC

Hip symptom/complaint

2.4

71.1

684

3117

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

357.6

70.8

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

64.1

70.6

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

8.5

70.5

159

193

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

33.5

70.0

WZA90

NOMESCO Finland

Other doctors statement

2.1

70.0

994

5411

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

69.7

1271

7622

M16.7

ICD-10 Finland

Other secondary coxarthrosis

688.2

69.2

A02BC03

ATC

lansoprazole; oral

1.9

68.6

1396

8695

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

5.9

67.9

198

347

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

67.7

467

1760

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

54.2

67.1

212

Kela drug reimbursment

Gout

+∞

66.8

ACC51

NOMESCO Finland

Release of median nerve

3.1

66.8

402

1383

M02AA07

ATC

piroxicam; topical

1.8

66.5

1731

11664

NDG74

NOMESCO Finland

Fusion of first IP joint

50.8

66.4

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

30.2

66.1

WZA00

NOMESCO Finland

Short statement of of health and health related matters

4.0

65.8

280

733

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

+∞

65.8

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

65.8

958

5252

9284

FHL

Wrist ossification surgery

331.7

65.6

M01AB01

ATC

indometacin; systemic, rectal

3.1

65.3

388

1322

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.7

65.3

307

876

N02AA05

ATC

oxycodone; systemic

2.3

65.1

660

3078

M01AX01

ATC

nabumetone; oral

4.0

64.8

277

728

M79.7

ICD-10 Finland

Fibromyalgia

6.3

64.7

180

297

NDG76

NOMESCO Finland

Fusion of DIP joint

13.8

64.4

113

NH3AE

NOMESCO Finland

Feet ultrasound examination

74.3

64.3

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.8

63.7

456

1755

ND1AA

NOMESCO Finland

Wrist X-ray examination

3.1

63.7

385

1328

NDF10

NOMESCO Finland

Synovectomy of wrist

219.6

63.3

RT271

NOMESCO Finland

219.6

63.3

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

51.4

63.2

A02BC05

ATC

esomeprazole; systemic

1.7

63.2

1853

12892

WX002

NOMESCO Finland

Sedation and analgesia

2.0

61.2

881

4789

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

27.6

61.0

M01AX05

ATC

glucosamine; oral

2.1

61.0

813

4283

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

605.8

60.9

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

+∞

60.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.7

60.5

278

778

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

595.5

59.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

59.4

376

1335

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

205.9

59.2

M01CC01

ATC

penicillamine; oral

205.9

59.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

59.0

2664

20792

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

58.9

631

3010

P01BA01

ATC

chloroquine; systemic

20.1

58.8

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

585.3

58.8

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

4.7

58.4

207

454

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

5.6

58.0

176

324

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.6

57.7

154

241

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

9.7

57.1

119

126

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.8

56.9

404

1544

L99

ICPC

Musculoskeletal disease other

7.1

56.8

143

206

R4110

NOMESCO Finland

Physiotherapy

1.8

56.7

1192

7411

D06BB04

ATC

podophyllotoxin; topical

3.7

56.5

263

744

J01MA12

ATC

levofloxacin; systemic

2.0

56.0

830

4549

L17

ICPC

Foot/toe symptom/complaint

1.8

55.9

1115

6806

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

55.9

507

2224

RF410

NOMESCO Finland

9.7

54.9

114

120

SPAT1229

SPAT

Assessment of need for aid

2.7

54.6

405

1586

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

54.4

1001

5938

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

12.1

54.1

100

M09AX01

ATC

hyaluronic acid; parenteral

4.8

53.7

185

394

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

53.6

558

2617

M19.2

ICD-10 Finland

Other secondary arthrosis

9.0

53.3

115

130

M01AB05

ATC

diclofenac; systemic, rectal

1.6

52.8

2882

23306

9531

FHL

Arthrodesis of the hand joint

24.5

52.8

RF420

NOMESCO Finland

8.2

52.8

121

151

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

15.3

52.0

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

113.3

51.9

M12.3

ICD-10 Finland

Palindromic rheumatism

513.4

51.5

L12

ICPC

Hand/finger symptom/complaint

2.1

51.3

644

3283

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.6

50.9

241

691

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

111.3

50.9

M10.9

ICD-10 Finland

Gout, unspecified

4.4

50.8

192

449

NH1AD

NOMESCO Finland

Ankle and foot CT

6.0

50.7

144

245

N06AA09

ATC

amitriptyline; systemic

2.3

50.5

504

2315

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

50.4

363

1397

A02BC01

ATC

omeprazole; systemic

1.7

50.0

1221

7906

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.8

49.6

222

607

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

10.0

49.1

100

102

H02BX01

ATC

methylprednisolone, combinations; systemic

3.0

49.1

297

1021

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

48.8

755

4182

J01CA04

ATC

amoxicillin; systemic

1.7

48.7

3528

30358

NHG82

NOMESCO Finland

Fusion of other tarsal joint

9.4

48.3

102

111

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.1

48.2

277

919

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.2

48.1

270

881

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

247.5

48.1

M06.3

ICD-10 Finland

Rheumatoid nodule

247.5

48.1

M05BX04

ATC

denosumab; parenteral

3.0

48.1

294

1019

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.3

47.8

151

292

K07.60

ICD-10 Finland

Snapping jaw

3.2

47.6

260

832

9272

FHL

Metatarsophalangeal joint resection

36.3

47.6

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.7

47.5

359

1418

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

47.5

486

2254

Z50.1

ICD-10 Finland

Other physical therapy

3.1

46.9

275

925

9314

FHL

Total knee endoprosthesis (also includes patellar part)

+∞

46.9

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.8

46.8

209

570

WX203

NOMESCO Finland

Infraclavicular plexus blockade

4.6

46.7

167

370

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

10.2

46.7

J01DA01

ATC

[U] cefalexin; systemic

1.6

46.4

2754

22367

318

Kela drug reimbursment

Teriparatide

44.3

46.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

46.3

483

2261

RF120

NOMESCO Finland

8.1

46.2

106

133

1220

FHL

Arthroscopy

4.2

45.9

180

437

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.2

45.8

253

817

L89

ICPC

Osteoarthrosis of hip

7.5

45.6

110

149

RF210

NOMESCO Finland

4.5

45.6

167

379

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

54.6

45.6

M35.7

ICD-10 Finland

Hypermobility syndrome

23.5

45.3

NHG20

NOMESCO Finland

Fusion of talocrural joint

16.5

45.1

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

45.0

482

2283

ND1AE

NOMESCO Finland

Wrist ultrasound examination

38.5

45.0

M04AA01

ATC

allopurinol; systemic

2.3

44.9

452

2081

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

44.8

593

3084

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

8.2

44.7

102

127

J01MA02

ATC

ciprofloxacin; systemic

1.6

44.4

1639

11818

9527

FHL

Alloarthroplasty, implant or endoprosthesis

441.8

44.3

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

44.1

555

2824

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

44.0

3950

35376

A02BA02

ATC

ranitidine; systemic

1.8

44.0

917

5617

M06.1

ICD-10 Finland

Adult-onset Still disease

154.8

43.8

M05.0

ICD-10 Finland

Felty syndrome

+∞

43.8

7165A

ICD-9 Finland

Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis

+∞

43.8

A46

ICD-10 Finland

Erysipelas

2.1

43.8

575

2975

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

43.5

1832

13624

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

43.3

952

5925

R60.0

ICD-10 Finland

Localized oedema

2.2

43.3

498

2437

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

43.2

1713

12546

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

44.6

43.2

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

20.0

43.1

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

6.2

43.0

119

196

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

80.9

42.9

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

42.6

920

5692

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

19.4

42.6

R5120

NOMESCO Finland

Preparation of an aid

4.2

42.6

168

410

M02AA10

ATC

ketoprofen; topical

1.9

42.5

727

4160

SPAT1263

SPAT

Sampling

1.6

42.3

1807

13458

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

79.2

41.9

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.2

41.8

135

268

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

5.1

41.7

136

273

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

+∞

41.7

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

41.3

241

807

M66.0

ICD-10 Finland

Rupture of popliteal cyst

7.2

41.2

102

144

H05AA02

ATC

teriparatide; parenteral

45.9

41.0

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

77.5

40.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

40.9

572

3032

WZC30

NOMESCO Finland

Teaching

2.0

40.6

608

3310

Z01.2

ICD-10 Finland

Dental examination

1.6

40.5

1659

12191

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

23.5

40.5

SPAT1216

SPAT

Assessment of functional ability

1.9

40.3

679

3857

S97

ICPC

Chronic ulcer skin

2.9

40.3

258

920

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3037467) Urinalysis macro (dipstick) panel - Urine

4186

27600

3.81

319.69

8.6

3.9

—

(3018010) Neutrophils/100 leukocytes in Blood

3857

17858

5.68

307.65

13.7

4.6

57.9

57.1

3.69

3747

16469

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1971

5565

5.13

307.65

1.4

1.2

iu/ml

46.9

20.3

9.42

663

1545

(3021440) Promyelocytes/100 leukocytes in Blood

1103

2766

4.81

307.65

5.8

3.7

0.1

0.2

0.97

260

787

(3002030) Lymphocytes/100 leukocytes in Blood

3881

18142

5.68

307.65

14.4

4.8

27.5

28.0

1.90

3764

16658

(3006315) Basophils [#/volume] in Blood

4123

18647

7.18

307.65

13.4

4.5

e9/l

0.0

3.41

3856

15683

(3002179) Metamyelocytes/100 leukocytes in Blood

1095

2655

4.97

307.65

5.2

3.6

0.4

0.7

2.99

219

614

(3021788) Differential panel - Synovial fluid

693

150

53.26

307.65

2.1

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

774

236

38.45

307.65

2.2

1.2

e6/l

9388.5

10399.6

0.16

617

163

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

856

296

34.51

307.65

1.9

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4566

29283

6.10

307.65

12.2

3.0

mm/h

14.0

12.3

12.24

4444

26543

(3006504) Eosinophils/100 leukocytes in Blood

3856

17514

5.84

307.65

14.1

4.7

2.7

2.9

5.51

3740

16074

(3044941) Cell count panel - Synovial fluid

460

155

32.50

307.65

1.8

1.1

—

(3019069) Monocytes/100 leukocytes in Blood

3865

17631

5.84

307.65

14.8

5.0

9.0

8.5

18.15

3754

16284

(3037522) Nuclear Ab [Titer] in Serum

1768

4152

5.97

307.65

1.5

1.2

titre

453.2

400.7

0.69

455

760

(40760892) CBC W Ordered Manual Differential panel - Blood

1913

8065

3.19

307.65

8.6

3.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4305

22525

6.68

307.65

16.9

8.3

e9/l

4.0

1.16

4046

19307

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

509

58.75

307.65

2.1

1.1

49.0

60.9

1.30

373

(3025159) Blasts/100 leukocytes in Blood

1068

2603

4.92

307.65

5.9

3.6

0.4

0.5

0.04

236

665

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

327

35.21

307.65

2.1

1.1

38.0

29.0

1.20

226

(3017181) Myelocytes/100 leukocytes in Blood

1147

2911

4.79

307.65

5.7

3.7

0.7

0.9

1.13

278

847

(3019198) Lymphocytes [#/volume] in Blood

4132

19154

6.96

307.65

13.6

4.6

e9/l

1.8

1.9

5.03

3897

16492

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

792

619

14.95

307.65

1.7

1.6

iu/ml

0.3

0.5

0.30

162

121

(42870588) Differential panel, method unspecified - Blood

3183

12359

5.15

307.65

12.1

4.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2061

5184

5.98

307.65

1.4

1.2

u/ml

24.5

2.8

8.55

794

1969

(3001604) Monocytes [#/volume] in Blood

4108

18555

7.10

307.65

13.3

4.5

e9/l

0.6

2.49

3838

15598

(3010144) Erythrocytes [#/volume] in Synovial fluid

271

28.85

307.65

1.9

1.1

e6/l

42913.7

194629.6

0.90

187

(3013115) Eosinophils [#/volume] in Blood

4162

19376

7.09

307.65

13.8

4.7

e9/l

0.2

11.01

3909

16639

(3022096) Basophils/100 leukocytes in Blood

3814

16931

5.89

307.65

14.2

4.7

0.7

13.43

3699

15559

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

502

793

6.91

307.52

2.0

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

280

208

14.18

301.95

1.5

1.1

iu/ml

29.5

22.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4483

31733

4.28

288.73

12.8

6.9

u/l

73.9

79.0

16.58

4394

29535

(3030905) Polymorphonuclear cells [#/volume] in Blood

394

576

7.33

258.56

3.8

3.1

e9/l

4.2

0.03

394

576

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2923

16924

2.69

257.04

2.6

2.1

nmol/l

80.0

79.0

1.11

2736

15006

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

399

604

7.08

253.52

4.0

3.4

57.4

57.6

0.05

399

604

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

155

38.95

252.94

1.6

2.8

mg/l

9.5

9.8

0.08

112

(3015171) Extractable nuclear Ab [Units/volume] in Serum

540

1111

5.31

250.23

1.3

1.2

u/ml

0.3

0.5

0.48

108

(3026493) Urate [Moles/volume] in Serum or Plasma

1915

9115

2.76

247.79

2.5

2.3

umol/l

1528.3

6309.2

10.61

1705

7794

(3035350) Ketones [Presence] in Urine by Test strip

3171

19381

2.67

245.26

5.7

3.4

estimate

0.0

0.80

802

3404

(3009261) Glucose [Presence] in Urine by Test strip

3196

19723

2.65

240.38

5.9

3.4

estimate

0.0

1.55

818

3371

(3021601) Nitrite [Presence] in Urine by Test strip

3169

19486

2.64

239.98

7.6

4.6

estimate

0.0

0.80

828

3414

(3008898) HLA-B27 [Presence]

461

859

5.80

237.93

1.0

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

825

2475

3.78

234.26

3.3

2.7

g/l

10.2

10.6

1.65

779

2225

(3021589) Normoblasts [#/volume] in Blood

2888

17482

2.49

218.16

17.9

8.3

e9/l

0.0

1.59

2606

13988

(3021879) Hepatitis B virus core Ab [Presence] in Serum

722

2135

3.77

208.15

1.2

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1157

4689

2.90

197.47

2.5

1.8

—

(3017732) Neutrophils [#/volume] in Blood

756

2474

3.41

185.63

4.8

2.7

e9/l

3.9

4.1

1.54

560

1931

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

365

693

5.59

183.77

1.2

1.1

u/ml

4.6

1.8

1.33

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

367

702

5.55

183.28

1.3

1.1

u/ml

5.2

4.0

0.45

(3015736) pH of Urine

2500

14999

2.30

181.30

5.1

3.2

—

5.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

918

3434

3.04

179.73

1.3

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

379

789

5.11

171.89

1.2

1.1

u/ml

22.8

28.8

0.22

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

314

551

6.01

171.71

1.2

1.1

u/ml

2.8

5.5

0.28

(3028026) IgM [Mass/volume] in Serum or Plasma

618

1961

3.45

158.17

1.8

1.9

g/l

1.1

1.4

3.29

573

1755

(3024263) Appearance of Synovial fluid

135

16.10

157.76

3.2

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1756

9513

2.29

157.24

2.6

2.1

mg/l

3.3

2.9

6.37

1569

7985

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

263

426

6.45

155.74

1.8

1.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3031

20600

2.15

150.45

6.4

6.2

mmol/l

1.2

2.94

2547

17209

(3004588) Protein electrophoresis panel - Serum or Plasma

660

2248

3.22

150.26

2.0

2.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

354

779

4.81

150.02

1.8

1.2

g/l

0.2

5.70

334

731

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1015

4427

2.61

145.88

1.4

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

358

815

4.65

145.47

1.8

1.2

g/l

1.2

1.08

341

767

(40758558) Short blood count panel - Blood

1789

10063

2.19

143.40

11.4

6.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

40.16

136.55

1.5

1.0

47.4

35.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2761

18612

2.05

133.77

5.7

5.5

mmol/l

1.2

2.85

2541

16644

(3004616) Nuclear Ab [Presence] in Serum

215

335

6.66

132.03

1.3

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1189

5830

2.35

131.01

2.4

umol/l

11.8

13.2

7.80

1108

5369

(3011397) Hemoglobin [Presence] in Urine by Test strip

1622

9179

2.12

124.56

5.6

3.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1098

5364

2.33

120.93

2.4

2.3

g/l

2.2

2.3

4.91

1022

4929

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

18.10

119.17

2.6

3.3

mg/l

5.9

7.5

1.01

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1041

5007

2.35

118.63

2.4

21.5

22.7

1.59

894

4280

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4786

41133

3.45

116.36

26.6

12.3

mg/l

17.6

24.6

64.43

4396

31505

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

18.89

115.26

2.5

au/ml

211.3

85.0

—

(3018095) Leukocytes [#/volume] in Urine

2173

13961

1.97

115.08

4.7

3.3

e6/l

97.4

120.2

0.42

1508

9654

(3020630) Protein [Mass/volume] in Serum or Plasma

706

2880

2.68

114.14

2.1

3.0

g/l

65.9

66.2

0.43

650

2602

(3009445) Proteinase 3 Ab [Units/volume] in Serum

421

1297

3.45

111.66

1.6

1.1

u/ml

23.7

5.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

149

186

8.22

111.40

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

149

186

8.22

111.40

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

149

187

8.18

110.90

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

149

188

8.13

110.41

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

149

188

8.13

110.41

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

149

188

8.13

110.41

1.3

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

27.79

109.26

1.5

1.1

g/l

38.4

35.8

—

(3029937) Albumin [Presence] in Urine by Test strip

1723

10494

1.97

104.21

6.9

3.7

estimate

0.0

1.60

826

3314

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

152

210

7.43

104.17

1.2

1.1

u/ml

36.3

35.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

146

199

7.52

101.25

1.2

1.1

u/ml

7.0

3.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

845

4060

2.29

94.63

2.9

2.4

1.9

1.8

1.02

762

3578

(3023520) Reticulocytes [#/volume] in Blood

679

2974

2.48

93.70

2.6

2.5

e9/l

71.2

69.2

0.66

514

2206

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2207

15056

1.82

90.44

6.5

3.6

—

(3018418) pH of Serum or Plasma

1886

12315

1.84

88.80

3.8

3.9

7.4

0.02

439

2283

(3041096) Erythrocytes [Presence] in Urine by Automated

1652

10415

1.86

86.56

5.4

3.2

—

(3023368) Bacteria identified in Blood by Culture

1628

10236

1.87

85.91

4.6

4.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2379

16784

1.78

85.50

3.1

2.7

ug/l

138.3

126.8

1.05

2211

15435

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2477

17699

1.77

85.04

4.4

3.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

235

583

4.18

84.97

1.2

1.1

u/ml

64.7

29.4

1.92

(3000850) Epithelial cells [#/volume] in Urine

1351

8062

1.92

83.41

3.1

2.4

e6/l

5.2

6.5

3.30

1210

6994

(3013166) Neutrophils/100 leukocytes in Synovial fluid

17.85

82.71

2.1

1.1

38.6

60.7

2.57

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

313

975

3.35

81.10

1.9

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2044

14009

1.76

79.44

4.4

2.9

—

(3032080) INR in Blood by Coagulation assay

2256

15904

1.75

79.37

8.9

8.4

inr

1.2

0.00

703

4613

(3021960) Folate [Moles/volume] in Serum or Plasma

1498

9393

1.84

78.35

1.7

1.5

nmol/l

22.5

20.8

1.64

1276

7953

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

318

1026

3.24

77.77

1.8

1.4

titre

667.5

183.0

1.94

(3039162) Centromere protein B Ab [Units/volume] in Serum

160

318

5.16

76.02

1.2

1.1

u/ml

68.1

33.0

—

(3045414) Leukocytes [Presence] in Urine

435

1693

2.71

75.92

2.1

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

413

1571

2.77

75.33

1.6

g/l

1.6

1.5

1.54

348

1333

(46235355) HIV 1 and 2 tests - Meaningful Use set

957

5234

2.02

75.25

1.5

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1218

7235

1.90

75.09

1.6

1.4

g/l

2.5

2.4

0.58

778

4185

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1178

3.03

74.19

2.1

2.8

g/l

3.3

3.0

4.78

276

908

(3036071) Salmonella sp Ab [Titer] in Serum

13.70

74.14

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1267

2.95

74.03

2.1

2.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1268

2.95

73.93

2.1

2.7

g/l

3.8

3.7

0.31

273

881

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

357

1269

2.95

73.82

2.1

2.8

g/l

7.6

7.2

2.71

281

931

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1770

11894

1.75

71.92

2.1

2.0

u/l

126.9

214.4

8.42

1665

11085

(3031040) Bacteria [#/volume] in Urine by Automated count

3394

27228

1.73

71.12

5.9

4.3

e6/l

2214.0

2526.6

0.10

392

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

273

853

3.32

70.27

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

232

658

3.65

69.37

1.4

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

310

1074

3.01

67.00

2.2

2.9

g/l

0.7

1.2

1.20

269

917

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

329

1189

2.89

65.89

2.0

2.8

g/l

10.1

10.3

0.42

287

988

(3024561) Albumin [Mass/volume] in Serum or Plasma

2387

17702

1.65

65.09

4.6

4.5

g/l

34.7

35.4

8.20

2221

16314

(3030467) Casts [#/volume] in Urine by Automated count

1631

10952

1.72

64.97

3.9

2.9

e6/l

0.3

0.5

2.50

1302

8049

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

183

460

4.09

64.93

1.5

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

779

4168

2.02

64.26

3.4

4.4

u/l

249.9

243.0

0.84

733

3936

(36304419) Bacteria [Presence] in Urine

1588

10651

1.71

63.15

3.7

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

276

935

3.06

61.99

2.1

2.8

g/l

0.0

0.1

1.49

256

845

(3002582) Erythrocytes [#/volume] in Urine

1728

11903

1.68

61.93

3.9

2.9

e6/l

53.3

68.8

0.26

1410

8903

(3034860) Kappa light chains.free [Mass/volume] in Serum

303

1091

2.89

61.03

2.6

4.0

mg/l

42.0

105.0

0.65

222

886

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

303

1092

2.89

60.93

2.5

4.0

mg/l

26.7

49.1

3.14

221

892

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

283

988

2.97

60.27

2.0

2.7

g/l

36.8

38.0

2.46

250

834

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

202

576

3.61

59.88

1.4

1.1

titre

56.7

23.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

293

1060

2.87

58.47

2.5

3.9

ratio

2.3

2.5

0.07

(3045424) Erythrocytes [Presence] in Urine

201

598

3.46

55.84

1.6

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

764

4263

1.93

55.20

2.1

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1005

6116

1.80

55.16

2.0

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

251

867

2.99

54.43

2.1

2.8

g/l

0.0

0.00

232

795

(3044927) Protein electrophoresis panel - Urine

130

290

4.57

53.85

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

651

3471

2.00

53.59

1.9

2.3

nmol/l

333.0

391.3

10.18

602

3158

(3004809) Band form neutrophils/100 leukocytes in Blood

194

580

3.44

53.48

3.0

3.5

1.0

1.5

1.08

155

457

(3019309) Folate [Moles/volume] in Red Blood Cells

1169

7490

1.73

53.41

1.8

1.7

nmol/l

1228.5

1179.6

0.96

920

5563

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

252

883

2.95

53.26

2.1

2.8

g/l

0.0

0.50

233

797

(40761535) Cells panel - Urine sediment

601

3155

2.03

51.57

5.6

3.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

240

846

2.93

50.16

1.6

1.2

iu/ml

17.3

7.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

190

585

3.33

49.99

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

235

821

2.95

49.91

2.3

4.1

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1607

11356

1.60

49.49

3.2

2.8

ng/l

1568.0

1348.3

1.16

1390

9698

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2223

16999

1.54

48.06

2.1

1.9

pmol/l

95.9

96.3

0.15

1225

8332

(3019225) pH of Specimen

709

4057

1.87

46.88

4.2

4.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

132

333

4.04

46.62

2.6

3.9

60.2

58.0

0.49

220

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

+∞

45.89

1.4

0.0

mg/l

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4400

39568

1.79

45.13

20.6

12.2

ml/min/173m2

81.7

79.2

13.27

3936

32067

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

484

2479

2.05

44.16

2.4

au/ml

22.4

23.9

0.10

145

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

234

879

2.74

43.41

1.5

2.1

mg/l

11.1

0.01

214

815

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

447

2247

2.08

42.86

1.3

au/ml

59.2

52.0

0.22

108

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

324

1438

2.34

42.30

1.5

2.0

u/l

36.9

39.9

1.98

290

1263

(3013826) Glucose [Moles/volume] in Serum or Plasma

2878

23656

1.49

41.72

5.0

4.4

mmol/l

6.6

6.7

3.84

2740

22000

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4801

44632

2.19

41.64

24.5

9.2

u/l

24.7

25.2

1.62

4743

42721

(3000494) Fungus identified in Specimen by Culture

747

4496

1.77

41.47

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

212

781

2.79

40.81

1.5

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1320

9253

1.57

40.50

2.6

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1234

8549

1.58

39.71

1.8

1.6

mg/l

1.3

1.2

1.05

983

6455

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2648

21527

1.48

39.70

5.6

6.3

umol/l

10.0

11.4

7.66

2512

20377

(3008757) Leukocyte morphology finding [Identifier] in Blood

128

357

3.65

39.24

3.1

4.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1015

6728

1.63

39.16

3.0

2.5

e6/l

0.9

1.7

1.28

623

3701

(3026782) Osmolality of Urine

1130

7718

1.60

38.45

3.1

2.6

mosm/kgh2o

506.8

535.4

4.86

993

6500

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

283

1234

2.37

38.43

3.2

2.8

—

(3007916) DNA double strand Ab [Titer] in Serum

13.55

37.36

1.1

1.0

—

(3044640) Blood type and Crossmatch panel - Blood

1647

12301

1.50

37.06

2.7

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

510

2823

1.90

36.94

1.8

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

6.35

36.70

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

421

2213

1.98

35.50

3.6

3.2

kpa

5.2

0.07

390

2053

(3009343) pH of Capillary blood

417

2186

1.99

35.43

3.6

3.2

7.4

0.00

281

(3019150) Specific gravity of Urine by Refractometry

1194

8422

1.54

34.78

7.3

3.7

kg/l

1.0

0.06

183

1265

(3037121) Protein [Mass/volume] in Urine

275

1248

2.27

34.01

2.6

3.1

g/l

0.3

0.20

108

480

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

301

1421

2.19

33.80

2.1

1.9

ug/l

1.8

1.6

0.05

265

1259

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

111

5.64

33.10

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

400

2116

1.97

33.06

3.5

3.2

mmol/l

2.0

0.00

299

1567

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1955

15430

1.43

31.74

4.1

3.4

ng/l

292.8

49.6

0.58

1452

10412

(3015377) Calcium [Moles/volume] in Serum or Plasma

1855

14519

1.43

31.45

2.7

3.5

mmol/l

2.3

2.4

2.92

1624

12572

(3013293) Extractable nuclear Ab [Presence] in Serum

15.96

31.43

1.6

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

574

3471

1.74

30.80

3.5

3.7

mmol/l

1.2

0.11

530

2946

(3014051) Protein [Presence] in Urine by Test strip

212

904

2.40

30.25

2.6

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

696

4464

1.65

29.89

2.0

2.1

ug/g

179.1

137.4

1.57

544

3450

(40768797) Stomach Pathology biopsy report

837

5617

1.59

29.84

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

739

4866

1.61

28.44

4.3

5.3

mmol/l

1.0

0.09

690

4504

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

306

1558

2.03

28.13

2.1

1.9

—

(3026008) Bacteria identified in Urine by Culture

1690

13208

1.42

28.07

3.7

3.0

—

(3013512) EKG study

1561

12044

1.43

27.81

4.2

3.8

—

(21494815) CD4 cells/100 lymphocytes in Specimen

252

3.62

27.51

1.7

2.2

43.4

44.6

0.11

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1177

8629

1.47

27.50

1.3

1.2

u/ml

1.6

1.8

0.21

302

2278

(3011412) CD3 cells [#/volume] in Blood

102

311

3.33

27.36

2.0

2.5

e9/l

1.0

1.1

0.54

182

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

645

4191

1.62

26.07

1.9

1.7

—

(3002385) Erythrocyte distribution width [Ratio]

3808

34324

1.43

25.85

29.3

15.6

14.2

13.7

57.66

3765

33428

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

618

3982

1.63

25.84

3.5

3.3

—

(40761536) Microorganisms panel - Urine sediment

548

3429

1.67

25.71

5.9

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

644

4202

1.61

25.56

1.8

1.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

216

3.70

25.04

1.7

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1610

12683

1.39

24.80

2.4

2.5

u/l

56.3

58.6

0.95

1479

11606

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

127

466

2.77

24.72

1.3

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

500

2.70

24.70

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

6.65

24.64

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

6.65

24.64

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

6.65

24.64

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

6.65

24.64

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

589

2.56

24.53

1.4

1.5

—

(3001729) Color of Synovial fluid

14.73

24.49

2.9

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1193

8934

1.44

24.49

1.7

1.6

pmol/l

450.3

33324617.4

7.00

986

7280

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

190

849

2.29

24.39

1.4

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

134

510

2.67

24.30

1.4

1.5

g/l

0.6

0.7

1.33

367

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

149

598

2.54

24.27

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4616

43435

1.63

23.67

20.4

15.0

mmol/l

139.4

139.7

16.62

4538

42151

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

121

445

2.76

23.46

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4622

43554

1.62

22.97

20.7

15.1

mmol/l

3.9

4.0

1.45

4534

42175

(3007566) Smooth muscle Ab [Titer] in Serum

209

1001

2.13

22.63

1.1

1.2

titre

204.3

180.8

0.08

(3042631) Mycobacterium sp identified in Specimen

129

503

2.60

22.32

2.7

2.9

—

(40762814) Titanium [Mass/volume] in Blood

+∞

21.89

2.0

0.0

ug/l

4.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

268

1424

1.93

21.78

2.0

1.7

—

(3022621) pH of Urine by Test strip

432

2651

1.69

21.71

4.6

2.8

—

(3022313) Gas panel - Capillary blood

289

1576

1.88

21.71

3.6

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

178

823

2.20

21.08

1.5

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

380

2275

1.72

20.90

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

870

6307

1.46

20.84

3.3

2.6

e6/l

3.0

3.2

0.22

485

3310

(40761511) CBC panel - Blood by Automated count

4592

43373

1.56

20.62

21.7

12.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

246

3.20

19.90

1.8

2.1

74.9

73.2

0.50

232

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

467

3004

1.61

19.45

3.2

3.4

ng/l

77.6

87.1

1.96

409

2534

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

251

1356

1.89

19.41

3.8

3.4

mmol/l

25.0

24.9

0.20

232

1243

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

103

387

2.70

19.23

8.5

6.5

mg/l

11.9

12.2

0.22

364

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

104

394

2.67

19.11

1.2

1.1

u/l

53.6

63.1

0.90

259

(3025941) Bacteria identified in Stool by Culture

350

2108

1.71

18.82

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

308

2.89

18.78

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

148

3.81

18.71

1.7

1.3

u/l

5.7

7.2

0.57

123

(3052851) Hemolysis interference index of Serum or Plasma

225

1187

1.94

18.70

3.5

3.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

466

3031

1.59

18.50

3.4

2.5

ml/min/173m2

65.4

65.0

0.08

198

1207

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4168

38810

1.40

18.47

5.2

4.9

mu/l

1.9

2.1

1.45

3828

35337

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

172

830

2.11

18.31

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

147

3.77

18.10

2.6

2.9

46.4

39.0

1.38

(3017704) Immunofixation for Urine

175

3.52

18.10

1.1

1.8

—

(3007461) Platelets [#/volume] in Blood

4839

46483

1.73

18.02

38.5

18.6

e9/l

260.6

252.8

12.37

4783

44982

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

241

3.10

17.93

1.8

2.1

15.5

14.3

0.24

(3010813) Leukocytes [#/volume] in Blood

4841

46523

1.72

17.78

38.4

18.6

e9/l

6.8

6.6

7.55

4775

44876

(3010503) CD19 cells [#/volume] in Blood

217

3.21

17.72

1.9

2.6

e9/l

0.1

0.5

0.70

211

(3024731) MCV [Entitic volume]

4839

46507

1.72

17.66

38.2

18.6

92.8

91.1

101.97

4810

45632

(3028192) IgG subclass 2 [Mass/volume] in Serum

319

2.79

17.63

1.4

1.3

g/l

2.7

2.8

0.30

209

(3024139) IgG subclass 3 [Mass/volume] in Serum

319

2.79

17.63

1.4

1.3

g/l

0.3

0.4

1.23

210

(3035941) MCH [Entitic mass]

4839

46510

1.72

17.61

38.1

18.5

30.6

30.3

21.63

4808

45636

(3026361) Erythrocytes [#/volume] in Blood

4839

46515

1.72

17.54

38.4

18.6

e12/l

4.3

4.5

101.73

4773

44877

(3027135) IgG subclass 1 [Mass/volume] in Serum

320

2.78

17.53

1.4

1.3

g/l

7.2

6.8

0.28

211

(3028626) Oxygen [Partial pressure] in Capillary blood

160

766

2.12

17.41

3.3

2.7

kpa

8.2

8.0

0.18

147

719

(3000963) Hemoglobin [Mass/volume] in Blood

4839

46525

1.71

17.39

38.6

18.7

g/l

130.6

134.3

68.34

4809

45667

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

210

3.22

17.31

2.2

2.6

e6/l

414.1

527.9

1.16

175

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

262

2.97

17.31

1.6

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

212

1126

1.92

17.28

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

197

3.28

17.04

2.3

2.7

e9/l

0.2

0.30

171

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

136

617

2.24

16.93

1.4

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

713

5190

1.43

16.40

23.3

23.5

inr

1.3

1.4

0.34

137

674

(4062490)

324

2.68

16.04

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

140

662

2.15

15.76

3.1

2.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.88

15.65

1.6

1.5

ug/l

0.3

0.5

1.99

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

702

5144

1.42

15.52

4.2

4.5

34.9

32.9

4.79

514

3323

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

139

664

2.12

15.25

3.3

5.5

iu/ml

586.3

549.8

0.05

(40768443) Skin Pathology biopsy report

286

1729

1.69

15.17

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

264

1572

1.72

14.81

1.1

u/ml

0.9

2.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

206

3.03

14.59

2.2

2.7

e6/l

753.9

733.4

0.04

102

(3015235) Bicarbonate [Moles/volume] in Capillary blood

171

903

1.92

14.24

3.4

2.9

mmol/l

24.8

25.2

0.56

146

803

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3557

32780

1.28

14.02

4.4

4.1

pmol/l

15.0

14.8

7.24

3237

29672

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

214

1222

1.78

13.91

2.1

2.2

ug/l

273.8

719.1

1.69

200

1162

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

380

2.42

13.78

1.4

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1544

12921

1.28

13.74

3.6

3.2

u/l

33.0

36.0

0.99

1450

12209

(3005011) Chlamydia sp Ab [Titer] in Serum

6.24

13.73

1.4

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

456

2.28

13.67

2.8

1.9

mg/l

23.9

24.1

0.01

119

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

107

483

2.24

13.56

1.3

1.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

120

574

2.12

13.18

1.1

—

(3016502) Oxygen saturation in Arterial blood

535

3846

1.44

13.05

7.7

7.4

95.3

95.6

0.63

517

3706

(36660697) Celiac disease serology panel - Serum

442

3081

1.48

12.66

1.2

—

(3022145) Colonoscopy Study observation

618

4583

1.40

12.62

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

305

2.48

12.07

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

305

2.48

12.07

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

305

2.48

12.07

1.5

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

148

789

1.90

12.03

3.0

2.4

15.9

16.2

0.49

393

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

115

3.50

11.93

1.5

2.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

216

2.75

11.73

1.2

1.1

u/l

25.4

19.7

0.63

179

(3037692) Legionella sp identified in Specimen by Organism specific culture

112

3.50

11.66

1.2

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

519

3786

1.41

11.63

2.0

2.1

g/l

0.2

0.35

489

3533

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

354

2.34

11.60

1.5

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

835

6571

1.32

11.57

2.7

3.2

mmol/l

0.8

1.77

782

6095

(3003327) Ova and parasites identified in Stool by Light microscopy

206

1236

1.69

11.30

1.9

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

989

7991

1.29

11.26

2.6

3.1

mmol/l

2.5

0.11

865

6974

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

107

3.48

10.96

1.1

—

(3019060) Gas panel - Arterial blood

361

2492

1.48

10.86

5.1

4.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

448

3232

1.42

10.68

5.3

7.0

mmol/l

9.9

9.5

0.64

418

3069

(3000570) Elastase.pancreatic [Mass/mass] in Stool

196

1181

1.69

10.60

1.3

1.4

ug/g

273.2

273.5

0.01

109

685

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

223

2.62

10.53

1.2

1.1

u/l

87.4

84.6

0.08

191

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

320

2170

1.51

10.51

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4065

38500

1.27

10.49

5.7

5.5

mmol/mol

38.8

39.8

7.54

3766

35120

(3017569) Oxygen content in Arterial blood

168

2.87

10.41

1.6

2.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

121

3.24

10.38

2.0

1.9

ug/l

57.5

55.5

0.08

116

(3000330) Specific gravity of Urine by Test strip

313

2119

1.51

10.36

3.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

484

2.07

10.35

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

304

2.35

10.27

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

120

631

1.92

10.23

1.5

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

250

2.50

10.22

1.1

titre

147.1

162.5

0.08

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

100

494

2.04

10.18

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2662

24181

1.21

10.06

2.9

2.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

577

4389

1.35

9.99

7.6

6.9

kpa

5.1

0.16

550

4178

(3006184) Hemoglobin [Mass/volume] in Capillary blood

146

825

1.79

9.93

2.6

2.1

g/l

127.1

128.6

0.32

111

585

(1616796) Gas panel - Central venous blood

145

819

1.79

9.88

3.1

3.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

486

2.04

9.88

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

576

4388

1.35

9.87

7.6

6.9

kpa

12.3

12.6

0.45

548

4181

(3003396) Base excess in Arterial blood by calculation

576

4390

1.35

9.84

7.7

6.9

mmol/l

1.4

1.1

1.13

467

3441

(3009508) Creatinine [Moles/volume] in Urine

1442

12347

1.23

9.82

3.1

3.0

mmol/l

6.9

7.1

1.76

1218

10275

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

349

2.22

9.78

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

151

866

1.77

9.78

1.4

1.3

—

(44806118)

382

2.17

9.74

1.5

1.4

—

(44790048)

382

2.17

9.74

1.5

1.4

—

(44790047)

382

2.17

9.74

1.5

1.4

—

(44790049)

382

2.17

9.74

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

483

2.03

9.68

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

486

2.02

9.52

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

194

2.65

9.49

1.3

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

487

2.01

9.47

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

286

2.32

9.33

1.3

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

103

532

1.96

9.29

1.2

u/ml

3.2

3.0

0.03

163

(3000060) B lymphocytes [#/volume] in Blood

3.82

9.21

1.6

2.2

e6/l

71.4

175.9

1.85

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

228

3429

0.65

9.20

1.6

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

198

2.59

9.13

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

164

2.76

9.10

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

164

2.76

9.10

1.3

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

153

2.83

9.09

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

479

3598

1.37

8.98

8.4

7.7

g/l

117.6

120.8

3.10

465

3463

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

446

3313

1.38

8.96

3.1

2.7

ng/l

189.1

194.9

0.12

403

3030

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

2.47

8.93

1.3

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

505

1.96

8.92

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.16

8.87

1.0

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

334

2365

1.44

8.83

8.3

7.0

mmol/l

24.8

24.6

0.51

307

2214

(3014148) Varicella zoster virus Ab [Titer] in Serum

398

2.08

8.81

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1368

11784

1.22

8.58

3.1

mg/l

391.2

333.9

0.17

889

7025

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

6.38

8.52

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.53

8.49

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

148

2.78

8.47

1.6

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

421

2.01

8.30

1.1

—

(3045142) Bone marrow Pathology biopsy report

442

1.99

8.27

1.2

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

408

2.03

8.26

1.3

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

451

3401

1.36

8.24

6.6

6.3

mmol/l

1.4

1.3

0.44

435

3284

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

160

980

1.65

8.22

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

151

2.73

8.17

1.2

1.1

u/ml

16.0

3.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

247

2.32

8.11

1.5

u/l

5.2

5.8

0.13

114

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

777

6327

1.27

8.10

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.47

8.08

1.0

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

764

6220

1.27

7.97

2.1

2.0

29.7

0.01

735

6033

(4024509)

403

2.00

7.81

1.5

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2852

26394

1.18

7.80

3.3

2.9

u/l

54.0

47.0

2.59

2656

24348

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

106

3.03

7.72

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

176

1123

1.59

7.68

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1425

12444

1.20

7.59

3.9

3.8

mg/mmol

8.7

8.5

0.06

915

7495

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

300

2145

1.42

7.56

2.6

2.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

174

1114

1.58

7.50

1.2

—

(3000012) Reticulocyte production index

207

2.38

7.41

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

239

2.27

7.36

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

941

7913

1.23

7.32

4.0

3.5

ng/l

225.8

508.5

1.43

731

6108

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

331

2.07

7.32

1.2

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

175

1129

1.57

7.31

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

352

2.03

7.27

1.8

2.4

—

(3014271) Vancomycin [Susceptibility]

173

2.50

7.23

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

255

1787

1.45

7.18

1.1

titre

412.0

221.7

—

(40768804) Tissue Pathology biopsy report

1960

17667

1.18

7.15

2.1

—

(3046861) Legionella sp Ag [Presence] in Urine

7.71

7.12

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

127

762

1.68

7.11

3.5

3.0

nmol/l

0.8

0.07

107

576

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

924

1.62

7.10

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

510

1.84

7.10

1.3

1.2

u/ml

3.7

4.1

0.16

217

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

439

3375

1.33

7.06

2.2

2.3

ug/l

5.8

7.5

1.15

361

2928

(3010421) pH of Blood

160

1021

1.59

7.02

2.9

3.7

7.4

0.75

136

833

(3023419) Bacteria identified in Sputum by Culture

462

1.88

7.00

2.1

2.6

—

(3004451) EKG impression Narrative

178

2.43

6.83

1.5

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1518

0.56

6.76

1.8

1.7

mg/l

5.7

3.4

0.89

1030

(4268621)

357

1.97

6.66

2.4

2.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.99

6.64

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.99

6.64

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

202

1377

1.49

6.57

2.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

100

2.91

6.57

1.1

1.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

200

2.31

6.57

1.1

u/l

20.3

27.0

0.61

141

(3005322) IgE [Units/volume] in Serum or Plasma

314

2328

1.37

6.43

1.3

u/ml

136.9

194.4

1.51

288

2139

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

202

2.29

6.43

1.1

u/l

65.8

85.8

1.55

145

(3012501) Base excess in Blood by calculation

136

856

1.60

6.35

3.0

3.7

mmol/l

2.4

2.6

0.26

107

590

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

216

2.23

6.34

2.1

1.8

u/field

1.3

2.9

0.90

150

(3002619) Bacteria identified in Specimen by Culture

3.45

6.28

2.0

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

954

1.57

6.26

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

422

1.86

6.26

3.1

20.6

mmol/l

7.3

7.5

0.18

347

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

291

2.04

6.19

1.5

u/ml

16.4

18.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

2.29

6.18

1.5

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

226

1596

1.44

6.15

5.4

5.3

1.6

0.08

216

1496

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

102

602

1.71

6.12

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

239

2.15

6.11

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.09

6.03

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

106

2.75

5.94

2.5

3.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

155

2295

0.67

5.87

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

153

1011

1.53

5.82

1.1

u/ml

4.0

8.8

—

119

(3045716) Anion gap in Serum or Plasma

161

2.37

5.79

4.1

2.4

mmol/l

9.2

9.3

0.05

122

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.61

5.75

1.1

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

193

2.24

5.75

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

2.24

5.75

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

193

2.24

5.75

1.6

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

181

2.28

5.70

1.1

—

(3028433) Virus identified in Specimen by Culture

103

2.73

5.68

1.0

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

601

1.68

5.65

1.2

u/ml

314.6

268.2

0.85

367

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.29

5.57

1.7

1.6

—

(3044889) 12 lead EKG panel

3121

29469

1.15

5.54

4.0

3.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

314

2387

1.34

5.50

9.0

8.3

1.3

1.4

0.60

308

2375

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

237

2.08

5.46

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

598

4942

1.24

5.41

7.6

6.5

mmol/l

104.2

104.4

0.48

579

4842

(3003338) MCHC [Mass/volume]

3371

35305

0.87

5.29

33.4

16.4

g/l

329.4

331.9

48.15

3344

35005

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

103

637

1.63

5.24

1.3

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

2.51

5.19

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

262

1958

1.36

5.16

2.8

2.5

e6/l

0.2

0.3

0.65

256

1900

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

139

2.38

5.13

1.5

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4364

42374

1.20

5.07

4.8

4.9

mmol/l

2.7

2.8

17.88

4012

38644

(3035880) pH of Pleural fluid

204

2.12

5.06

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

310

2384

1.32

5.04

9.1

8.4

0.7

0.60

304

2371

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

357

4507

0.78

5.00

1.6

—

(3047181) Lactate [Moles/volume] in Blood

168

1173

1.45

4.93

6.7

6.5

mmol/l

1.4

1.3

0.72

146

1028

(3014007) Fractional oxyhemoglobin in Arterial blood

308

2382

1.31

4.82

9.2

8.5

93.5

94.0

0.54

308

2375

(1761868) Lipid panel - Serum or Plasma

1311

14574

0.87

4.80

2.8

2.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

521

1.66

4.77

1.1

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.17

4.75

4.1

2.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

117

765

1.54

4.74

2.5

2.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.79

4.70

1.6

ug/l

9.1

9.4

0.11

(3035320) C reactive protein [Mass/volume] in Body fluid

266

1.93

4.67

2.5

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

563

1.63

4.67

1.3

1.4

u/ml

113.6

114.6

0.04

111

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

352

1.80

4.66

2.9

2.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

178

2.14

4.64

1.7

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.21

4.61

1.9

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

134

2.32

4.58

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

215

1590

1.37

4.56

5.9

5.4

0.8

0.9

1.36

204

1490

(3033658) Prothrombin time (PT) actual/Normal

1168

10404

1.16

4.55

4.2

3.7

91.8

91.2

0.33

1129

10134

(3048879) Bone marrow aspiration report

2.56

4.54

1.6

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4273

41500

1.18

4.51

4.4

mmol/l

4.7

4.8

5.31

3933

38012

(3016018) Differential panel - Cerebral spinal fluid

388

1.74

4.41

1.1

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

337

1.79

4.39

2.1

u/field

1.7

2.5

0.75

135

(3003181) Sodium [Moles/volume] in Urine

112

740

1.52

4.36

1.4

1.3

mmol/l

58.0

61.5

0.47

581

(3019977) pH of Arterial blood

217

1.99

4.34

4.6

2.9

7.4

0.41

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

101

653

1.56

4.34

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

170

2.13

4.33

3.6

4.2

—

(21494434) Karyotype in Bone marrow

332

1.79

4.29

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

184

1341

1.39

4.29

4.4

3.8

mmol/l

1.3

1.4

0.52

179

1320

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

369

2969

1.26

4.27

1.8

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

331

2629

1.28

4.26

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

217

0.23

4.24

8.2

11.7

nmol/l

866.0

832.3

—

210

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

139

2.24

4.24

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4239

41205

1.17

4.14

4.4

4.3

mmol/l

1.6

1.5

15.43

3891

37519

(3002032) Base excess in Venous blood by calculation

431

3542

1.24

4.14

3.5

mmol/l

2.1

1.9

0.41

347

2871

(3047189) Immunofixation for 24 hour Urine

167

2.10

4.12

1.8

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

432

3555

1.23

4.10

3.5

kpa

5.8

0.09

419

3453

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

161

1158

1.40

4.08

2.4

2.0

92.2

91.6

0.10

151

1074

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.01

4.06

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

3906

37762

1.14

4.05

26.5

13.9

38.8

39.3

3.41

2502

26711

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

155

2.14

4.05

1.6

2.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

511

1.59

3.90

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

238

1834

1.31

3.88

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

119

818

1.47

3.87

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

119

818

1.47

3.87

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

206

1.95

3.86

1.2

1.1

ratio

1.1

0.03

(3012441) Differential panel - Pleural fluid

420

1.65

3.84

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

139

2.17

3.82

1.1

ng/l

214.9

490.9

0.60

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.43

3.79

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.40

3.72

1.0

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

154

2.08

3.71

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

154

2.08

3.71

1.6

2.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.57

3.71

9.8

6.9

74.5

75.8

0.10

(3028679) Herpes simplex virus Ab [Presence] in Serum

161

2.06

3.70

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4085

39681

1.14

3.69

3.9

mmol/l

1.2

1.3

0.92

3724

35826

(3011325) HIV 1+2 Ab [Presence] in Serum

6.67

3.67

1.0

—

(3000991) Gas panel - Venous blood

384

3162

1.23

3.65

8.2

7.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.12

3.64

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

552

1.55

3.64

1.7

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

218

1.89

3.62

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

197

1.94

3.61

1.1

—

(3011985) Renin [Units/volume] in Plasma

539

1.55

3.56

1.7

1.4

mu/l

81.0

55.3

0.43

482

(3008536) Aspergillus sp Ab [Presence] in Serum

2.65

3.55

3.8

1.9

—

(3006270) Folate [Moles/volume] in Blood

368

1.67

3.54

1.2

1.1

nmol/l

367.4

358.2

0.13

306

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

3.54

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

225

1745

1.30

3.54

3.7

3.8

mmol/l

24.4

24.2

0.47

197

1574

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

258

2039

1.28

3.51

10.4

9.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

169

1261

1.35

3.48

3.6

2.8

u/ml

0.4

0.3

0.24

687

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

325

2643

1.25

3.48

2.8

3.4

pmol/l

4.3

4.5

3.82

289

2351

(3020891) Body temperature

201

1542

1.32

3.43

5.2

4.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

113

793

1.43

3.35

1.2

1.3

mmol/l

3.7

3.8

0.76

103

750

(3044009) aPTT.lupus sensitive (LA screen)

3.71

3.35

1.5

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

246

1.80

3.35

1.1

iu/ml

24.7

8.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

203

1.88

3.33

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

2.23

3.31

1.0

1.2

—

(3039000) Anion gap in Blood

119

846

1.42

3.29

7.9

7.5

mmol/l

10.8

11.2

0.79

109

756

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

162

1.98

3.28

1.2

—

(3018572) Chloride [Moles/volume] in Blood

119

847

1.41

3.27

7.9

7.5

mmol/l

105.0

105.2

0.26

109

757

(4306422)

535

1.52

3.26

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.58

3.21

1.1

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

127

919

1.39

3.19

2.7

mg/l

1.6

1.5

1.05

107

836

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

171

1.94

3.18

2.9

3.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

288

1.71

3.16

1.1

1.2

titre

—

(4015189)

2.25

3.12

2.3

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

297

1.69

3.11

1.6

2.5

—

(21494755) Public health laboratory ask at order entry panel

273

3354

0.80

3.10

1.3

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.33

3.07

1.9

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

391

1.59

3.07

1.1

91.4

96.6

0.78

367

(3006462) Nitrate [Presence] in Urine

202

1.84

3.06

7.2

3.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.51

3.05

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.44

3.04

1.3

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

119

2.11

3.03

1.4

1.5

1.4

2.4

0.65

108

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

250

2010

1.26

3.00

9.4

8.7

mmol/l

24.9

24.3

2.02

234

1892

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

1.98

2.99

1.1

miu/ml

1504.0

1536.0

0.06

147

(3024891) Influenza virus A+B Ag [Presence] in Specimen

133

983

1.36

2.96

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

294

1.67

2.96

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.83

2.91

1.0

1.2

—

(4211845)

221

1.77

2.88

6.9

2.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.93

2.85

1.1

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

498

1.49

2.78

1.4

1.3

pmol/l

448.9

344.9

0.60

387

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

117

2.06

2.76

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.98

2.69

1.1

1.2

u/l

17.4

24.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.22

2.67

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

257

1.68

2.66

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.18

2.66

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

151

1159

1.31

2.65

4.9

4.0

mmol/l

3.8

3.9

0.92

139

1090

(3044290) Cell count panel - Cerebral spinal fluid

103

747

1.39

2.62

1.2

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4191

40999

1.12

2.60

4.3

4.5

mmol/l

5.8

5.9

5.41

3794

37051

(3016038) Potassium [Moles/volume] in Urine

259

1.67

2.60

1.2

1.1

mmol/l

29.3

33.7

0.84

216

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

275

1.64

2.58

1.2

1.5

mmol/l

2.4

2.1

0.76

263

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

107

2.06

2.56

1.2

1.3

ug/l

4.2

420.8

1.32

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1224

11301

1.11

2.56

1.7

1.6

mmol/l

1.3

0.20

1014

9390

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.36

2.55

1.1

1.2

mmol/l

1.3

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

248

1.66

2.45

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

562

1.43

2.45

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

226

1.69

2.42

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

140

1080

1.30

2.40

3.0

2.3

208.3

194.8

0.88

129

1019

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

227

1.68

2.39

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.75

2.37

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

190

1.74

2.36

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

190

1.74

2.36

1.3

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

121

917

1.33

2.36

1.2

1.3

mg/l

638.1

505.9

1.01

113

868

(3020650) Glucose [Presence] in Urine

104

2.02

2.35

2.1

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

213

1.70

2.35

1.1

nmol/l

2.3

12.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

544

1.42

2.31

1.1

au/ml

21.9

12.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

553

1.42

2.30

1.4

g/l

33.0

33.1

0.04

489

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

4.62

2.27

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.62

2.27

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.48

2.27

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.89

2.25

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

278

1.59

2.25

1.1

1.3

u/ml

0.0

0.9

1.57

132

(3019174) dRVVT (LA screen)

3.11

2.22

1.6

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

135

1.86

2.21

1.4

50.8

66.4

0.89

119

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

217

1.66

2.21

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

343

1.52

2.21

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

272

1.59

2.19

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

551

0.61

2.16

4.7

5.1

umol/l

361.7

363.3

0.02

481

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

183

1.70

2.07

1.2

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.91

2.07

1.3

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

574

1.38

2.06

1.1

1.3

u/l

122.7

34.3

0.99

504

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

985

9091

1.10

2.05

4.7

5.0

ug/l

2.2

3.5

2.07

866

8111

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.98

2.05

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

526

1.39

2.00

1.1

124.2

118.1

0.76

464

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.96

1.99

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

1.55

1.99

1.3

—

(3000492) Spirometry study

406

3565

1.15

1.96

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

339

2938

1.16

1.96

3.0

2.9

kpa

4.4

4.6

1.42

329

2844

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.94

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.55

1.94

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

164

1.71

1.94

1.4

1.2

—

(3036489) Thrombin time

177

1448

1.23

1.93

2.4

1.9

21.9

21.4

0.32

158

1270

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

185

1522

1.22

1.91

1.7

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

106

1.89

1.90

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.83

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

310

1.49

1.82

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

494

1.38

1.81

1.5

1.4

e6/l

5665.6

1844.1

1.01

353

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.57

1.80

1.1

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.96

1.79

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

398

0.60

1.73

1.4

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

530

0.66

1.71

2.1

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

510

1.36

1.67

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.18

1.67

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

244

1.52

1.64

1.1

1.2

mg/l

41.6

38.9

0.16

199

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

102

800

1.28

1.64

1.2

1.4

e6/l

38.8

18.3

0.85

615

(4281824)

631

0.69

1.64

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

127

1.74

1.63

2.1

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

102

801

1.28

1.63

1.3

1.5

e6/l

191.2

1380.6

2.60

650

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

546

0.68

1.61

1.3

1.2

mmol/l

7.9

7.7

0.14

401

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

128

1.72

1.60

1.5

1.3

—

(44813793)

256

1.49

1.55

1.1

—

(3016750) Collection duration of Urine

216

1.53

1.6

2.1

min

468.9

502.0

1.08

161

(3030313) Adrenal Ab [Titer] in Serum

3.34

1.52

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.59

1.51

1.3

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

193

1.56

1.50

1.0

1.1

u/l

1.2

1.1

0.34

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.16

1.50

1.6

2.7

—

23.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.16

1.50

1.3

1.5

—

(3023410) Appearance of Cerebral spinal fluid

358

1.40

1.50

1.3

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

401

1.38

1.48

4.5

5.2

u/ml

152.8

82.6

0.24

111

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

433

3900

1.12

1.47

2.6

2.4

u/l

36.7

50.3

0.55

363

3320

(3051611) Lipemic interference index of Serum or Plasma

436

1.36

1.47

4.8

3.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

155

1.62

1.46

1.6

2.2

umol/l

79.3

141.1

0.98

(3034274) Bile acid [Moles/volume] in Serum --fasting

343

1.40

1.46

2.2

1.9

umol/l

10.1

7.1

0.25

243

(3001019) Free T4 and TSH panel - Serum or Plasma

176

2068

0.85

1.41

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

346

1.39

1.40

2.4

2.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.77

1.38

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.38

3.1

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

198

0.50

1.38

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

511

1.32

1.37

1.0

1.1

g/l

1.5

0.03

459

(3023183) Ammonium ion [Moles/volume] in Plasma

759

1.26

1.37

2.1

2.9

umol/l

28.0

34.1

2.69

644

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.61

1.36

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

104

1.73

1.36

2.0

1.4

—

(40768793) Breast Pathology biopsy report

106

1302

0.81

1.36

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.94

1.36

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

129

1067

1.21

1.35

1.6

1.8

iu/l

3.4

4.4

0.54

393

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.76

1.34

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.13

1.33

1.4

2.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

358

1.37

1.33

4.1

3.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

564

5183

1.10

1.33

8.2

6.3

—

(3034426) Prothrombin time (PT)

128

1.64

1.33

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

476

0.69

1.32

1.0

1.1

—

(44806071)

2.09

1.30

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

1.30

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.84

1.29

1.0

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.89

1.28

1.4

ng/l

94.7

114.2

0.23

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.89

1.28

1.2

—

(40765096) Chromosome analysis panel by Banding

107

1.68

1.25

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

635

1.26

1.24

1.2

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1131

10726

1.07

1.23

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

163

1.54

1.22

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.04

1.22

1.4

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.63

1.21

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.63

1.21

4.2

4.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.16

1.21

1.4

2.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

522

1.29

1.21

1.1

u/ml

2.7

0.01

233

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

331

1.36

1.20

1.2

—

(3036603) Volume of Urine

264

1.40

1.18

1.5

1938.3

1868.7

—

(3045788) Cell count panel - Pleural fluid

393

1.33

1.17

1.5

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.93

1.17

1.2

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

455

1.30

1.16

1.5

1.4

e6/l

37080.1

65640.5

0.74

272

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

474

0.72

1.15

2.1

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

527

1.27

1.14

1.2

1.3

nmol/l

—

(40768806) Pleura Pathology biopsy report

457

1.29

1.13

1.6

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

539

0.74

1.11

2.3

2.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.38

1.09

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.38

1.09

1.2

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.38

1.09

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.19

1.08

1.3

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.76

1.06

1.6

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.65

1.06

1.1

u/ml

0.4

1.9

—

(4010399)

321

2907

1.11

1.05

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

120

1016

1.19

1.04

1.3

miu/ml

201.8

229.7

0.36

475

(3027273) Bicarbonate [Moles/volume] in Venous blood

217

1923

1.13

1.03

3.3

3.1

mmol/l

25.1

25.2

0.11

212

1868

(3019897) Erythrocyte distribution width [Ratio] by Automated count

498

0.74

1.03

6.9

2.6

13.4

13.1

0.66

490

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

608

1.24

1.02

1.2

1.3

nmol/l

0.1

0.3

—

(3008295) Osmolality of Serum or Plasma

403

1.29

1.01

1.4

mosm/kgh2o

273.5

276.7

0.48

303

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

1.39

1.01

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1145

0.84

0.99

1.6

1.5

—

(3051651) Icteric interference index of Serum or Plasma

257

1.36

0.98

4.9

3.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.81

0.98

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

131

1125

1.17

0.98

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.95

0.97

3.0

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

537

0.76

0.97

1.3

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

222

1985

1.12

0.94

1.1

—

(3004775) Volume in Urine collected for unspecified duration

303

1.32

0.93

1.7

2.4

695.3

608.5

0.64

203

(3047352) Trisomy 18 risk [Likelihood] in Fetus

522

0.76

0.93

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.73

0.92

2.7

2.9

u/field

0.9

0.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

159

1.45

0.91

2.1

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

508

4741

1.08

0.90

2.8

2.6

umol/l

6.0

8.8

4.18

421

4094

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

716

7569

0.94

0.89

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

135

1.48

0.89

1.4

5.4

mg/l

60.2

62.6

0.08

(3000034) Microalbumin [Mass/volume] in Urine

386

1.27

0.87

2.5

2.8

mg/l

37.3

19.4

0.43

278

(1761482) Bacteria [#/volume] in Urine by Culture

1129

0.85

0.87

4.4

4.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

305

2795

1.10

0.84

1.2

iu/ml

94.7

147.7

2.09

104

1068

(3011897) Casein IgE Ab [Units/volume] in Serum

1.78

0.84

1.3

1.1

—

8.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

535

0.78

0.83

1.6

1.5

—

(3035285) Chloride [Moles/volume] in Venous blood

546

0.79

0.83

2.3

2.2

mmol/l

104.8

105.3

0.24

537

(3041354) Potassium [Moles/volume] in Venous blood

546

0.79

0.83

2.3

2.2

mmol/l

4.0

4.1

0.48

537

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.74

0.82

2.3

2.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.74

0.82

1.0

—

(4133840)

1.65

0.81

1.1

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

147

1.43

0.80

25.7

26.3

ug/l

118.1

111.5

0.18

118

(3005033) Fetal Nuchal fold Thickness US

520

0.79

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

351

0.74

0.79

2.0

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

106

1.51

0.78

1.6

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

245

0.69

0.76

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.77

0.76

1.2

7.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.08

0.74

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

460

4897

0.93

0.73

3.2

4.1

ug/l

13.8

26.8

1.52

377

3985

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

283

1.27

0.69

5.6

6.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

169

1.36

0.69

2.1

2.4

—

(3051593) INR in Capillary blood by Coagulation assay

195

1.34

0.69

3.7

14.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.44

0.69

9.2

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

1.44

0.69

9.2

2.6

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.53

0.68

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

584

0.82

0.67

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

260

2818

0.92

0.67

3.4

4.0

u/ml

49.5

75.1

0.96

246

2709

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

566

1.19

0.67

1.2

1.3

—

(40768446) Kidney Pathology biopsy report

119

1.43

0.66

1.8

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

767

0.85

0.66

1.5

1.8

nmol/l

0.9

0.8

0.98

649

(3024869) Neuronal Ab [Presence] in Serum

1.61

0.65

1.1

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

666

0.84

0.63

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

501

0.82

0.61

1.5

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.59

0.61

1.6

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

609

1.17

0.61

1.4

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

212

1947

1.09

0.61

1.9

2.1

nmol/l

11.7

12.5

0.73

181

1704

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

113

1.42

0.61

2.0

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

102

900

1.14

0.60

3.4

3.3

u/ml

447.6

740.7

0.27

819

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.1

—

8.5

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

5.7

—

(3024928) Oxygen saturation in Venous blood

799

1.14

0.59

3.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

201

1.30

0.58

1.2

1.0

u/ml

0.6

3.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

166

1.33

0.58

1.7

2.0

157.3

143.7

0.28

156

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

149

1641

0.91

0.57

3.0

3.5

u/ml

247.6

3975.8

1.42

129

1406

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

310

1.23

0.56

1.3

mmol/l

9.2

11.7

2.49

(3035637) Corticotropin [Mass/volume] in Plasma

494

1.18

0.56

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

194

1.29

0.55

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

691

1.15

0.55

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

308

2889

1.07

0.54

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

394

1.19

0.54

1.2

2.0

—

3.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

116

1.38

0.54

1.1

1.2

34.6

29.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.46

0.54

2.0

4.8

u/l

35.0

40.5

—

(3000285) Sodium [Moles/volume] in Blood

1.48

0.53

1.2

1.0

—

(3027008) Opiates [Presence] in Urine

940

0.88

0.53

1.9

1.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.54

0.53

1.0

1.1

u/ml

0.3

0.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.50

0.51

1.8

2.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.50

0.51

1.0

1.1

—

(44806420)

135

0.67

0.51

2.1

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

257

2403

1.07

0.51

3.2

3.1

g/l

125.1

128.7

1.73

248

2353

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

106

1179

0.90

0.51

1.7

1.8

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.50

1.0

—

(3028300) Cannabinoids [Presence] in Urine

945

0.89

0.49

1.9

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

216

1.25

0.49

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

554

5316

1.05

0.47

3.0

ug/l

0.7

0.8

2.06

398

3585

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

309

1.20

0.46

1.4

1.2

—

(4146454)

419

0.83

0.46

2.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

622

0.87

0.46

1.4

—

(3027944) Amphetamines [Presence] in Urine

928

0.89

0.45

2.0

1.7

—

(40757373) Influenza virus identified in Isolate

0.59

0.45

1.0

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

621

0.87

0.45

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

621

0.87

0.45

1.3

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

165

1.27

0.44

1.1

1.2

nmol/l

150.9

136.1

0.49

165

(3044007) Cell count panel - Peritoneal fluid

141

0.71

0.44

2.8

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

620

0.87

0.44

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

175

0.74

0.44

1.2

1.5

—

(3011648) Oxygen content in Venous blood

297

0.81

0.44

2.0

10.3

11.1

0.45

297

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.45

0.44

1.7

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

936

0.90

0.44

1.9

1.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.40

0.0

10.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

114

1.32

0.40

2.6

2.4

ug/l

1.5

1.2

0.16

108

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

168

1.25

0.40

1.7

nmol/l

1.7

7.0

1.12

133

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.39

0.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

801

0.90

0.38

1.3

u/l

17.6

13.0

1.36

660

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.36

0.38

1.0

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.39

0.38

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.39

0.38

1.2

1.8

umol/l

38.6

41.1

—

(4034850)

129

1394

0.92

0.38

14.1

8.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

197

1.22

0.37

1.2

1.0

u/ml

0.6

0.9

—

(3016879) Cocaine [Presence] in Urine

862

0.90

0.37

1.9

1.8

—

(3033799) Differential panel - Peritoneal fluid

143

1.26

0.36

2.2

1.8

—

(3002256) Pathology report gross observation

595

5761

1.04

0.36

1.3

—

(1002224) Polysomnography panel

135

1451

0.93

0.35

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.35

1.8

2.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.35

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.33

0.33

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.33

0.33

9.8

9.9

mmol/l

3.7

5.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

165

1753

0.94

0.32

1.8

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

285

0.84

0.32

1.0

ng/l

362.9

340.1

0.16

200

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

407

1.13

0.32

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.30

0.30

24.4

8.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

293

0.85

0.30

1.6

1.7

—

(3014891) Appearance of Pleural fluid

1.27

0.30

1.4

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

101

1087

0.93

0.29

1.8

1.7

mu/l

297.1

319.9

0.39

986

(4027681)

185

1.19

0.29

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

122

1301

0.94

0.28

1.6

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

424

4107

1.04

0.27

1.5

1.7

1.6

1.4

2.45

354

3597

(3020191) Ethanol [Moles/volume] in Serum or Plasma

261

1.15

0.27

1.1

1.5

promille

0.8

1.2

0.88

200

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

131

1.22

0.27

2.3

2.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

113

1.24

0.26

1.1

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

289

0.86

0.26

1.0

ng/l

46.7

46.1

0.02

200

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.30

0.26

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

287

0.87

0.24

1.0

ng/l

738.1

690.0

0.25

192

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

928

1.07

0.24

2.0

2.4

ug/min

53.0

93.7

1.25

562

(3052592) Norovirus Ag [Presence] in Stool

1.17

0.24

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.71

0.24

8.5

—

(3020491) Glucose [Moles/volume] in Blood

284

1.13

0.23

1.5

1.6

mmol/l

7.8

6.6

0.63

191

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

318

3078

1.04

0.23

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

370

1.11

0.23

1.1

1.8

—

1107.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.32

0.23

1.0

1.3

umol/24h

1.5

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

158

1655

0.95

0.22

1.6

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

897

0.94

0.22

4.4

3.3

mg/l

34.8

27.5

0.71

559

(3050129) First trimester maternal screen panel - Serum or Plasma

732

0.93

0.22

1.5

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

253

2441

1.04

0.22

1.5

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.22

0.22

3.8

5.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.19

0.21

1.2

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.0

—

3616.7

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

1.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

182

1.15

0.21

1.3

1.4

pmol/l

62.7

61.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

201

1.14

0.21

1.2

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

719

0.93

0.21

1.7

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

220.8

—

(3011288) Drugs identified in Urine by Screen method

636

0.93

0.20

1.7

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.20

0.19

1.0

1.5

—

(4035726)

404

4139

0.97

0.19

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

161

1675

0.96

0.18

1.4

1.3

iu/l

37.8

33.3

0.76

140

1444

(3022689) Creatine [Moles/volume] in Urine

100

1.20

0.18

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

100

1.20

0.18

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

100

1.20

0.18

1.0

1.1

—

3.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

147

1.16

0.18

1.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.19

0.18

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.19

0.18

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.19

0.18

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.17

0.17

1.1

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

568

0.93

0.17

1.1

u/ml

3.0

4.0

0.33

262

(3023430) Cat dander IgE Ab [Units/volume] in Serum

419

0.93

0.14

1.1

u/ml

1.4

2.9

0.97

147

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

429

0.93

0.14

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

191

0.89

0.13

1.5

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

170

0.88

0.13

2.3

2.0

e6/l

1544.4

3730.2

—

116

(40768441) Liver Pathology biopsy report

305

1.08

0.13

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

542

1.05

0.11

1.1

—

(3025130) Human papilloma virus identified in Specimen

609

0.95

0.11

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

582

1.05

0.11

1.1

iu/ml

42.1

19817.3

0.55

120

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

516

0.95

0.11

1.3

u/l

36.3

31.9

0.32

418

(40768795) Lymph node Pathology biopsy report

437

1.05

0.10

1.3

1.2

—

(4212803)

1.11

0.09

1.2

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.09

0.09

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

513

0.95

0.09

1.1

u/ml

0.5

1.8

1.91

113

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.05

0.08

1.0

1.1

ug/l

90.7

76.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.78

0.08

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

154

0.91

0.08

1.9

2.4

umol/l

72.9

57.0

—

127

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.83

0.07

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

372

1.05

0.07

1.1

1.0

u/ml

0.0

0.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

143

0.91

0.07

1.7

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

100

975

1.03

0.07

2.1

u/l

8648.5

4236.8

0.45

404

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

108

1.11

0.07

1.1

8.1

—

54.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

147

1.09

0.07

1.2

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.05

0.07

1.1

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

185

1820

1.02

0.07

3.1

2.5

0.7

0.75

176

1747

(3002523) Influenza virus A Ag [Presence] in Specimen

541

1.04

0.07

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.86

0.06

7.6

8.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

287

1.05

0.05

1.0

1.1

—

(3024471) HLA-A [Type]

110

0.91

0.05

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

169

1.07

0.05

1.9

1.5

mmol/l

8.4

8.1

0.11

(4198724)

120

0.92

0.05

3.5

1.7

—

(4094501)

114

1121

1.02

0.04

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

635

0.98

0.04

1.1

u/ml

0.2

1.3

2.96

233

(3043410) Blood group antigens tested for on Red Blood Cells

101

1.09

0.04

1.6

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

170

0.94

0.04

1.1

1.0

83.8

91.5

—

125

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

301

0.96

0.03

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

188

1864

1.01

0.03

3.3

2.6

1.1

1.2

1.36

188

1850

(3024932) HLA-DR beta [Type]

108

0.93

0.03

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

679

1.02

0.02

1.7

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

153

1.05

0.01

1.1

1.4

—

1960443.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

453

1.02

0.01

1.1

u/ml

1.1

2.8

1.49

153

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

517

0.99

0.01

1.4

nmol/l

0.3

0.4

1.03

380

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

137

1376

1.00

0.00

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.05

0.00

1.2

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

452

1.00

0.00

1.4

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

184

0.98

0.00

1.1

—

5.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

544

0.99

0.00

1.1

u/ml

0.3

1.3

2.07

214

(3028707) Methadone [Presence] in Urine by Screen method

417

1.01

0.00

2.4

2.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.01

0.00

1.2

1.1

93.7

89.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

734

7339

1.00

0.00

4.0

4.3

21.4

22.1

0.61

379

3687

(3042733) HLA Ab [Presence] in Serum

0.98

0.00

3.8

4.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.94

0.00

8.5

8.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

170

1.00

0.00

1.3

1.0

u/ml

0.1

3.4

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.4

—

5.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.91

0.00

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

118.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

6.6

—

94.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

105.9

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

3.6

—

(4038314)

0.00

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

100

1.00

0.00

2.3

2.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint RHEUMA_SERONEG and mortality.

Females

Parameter	HR [95% CI]	p-value
RHEUMA_SERONEG	1.344 [1.24, 1.45]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.078

During the follow-up period (1.1.1998 — 31.12.2019), 3367 out of 15826 females with RHEUMA_SERONEG died.

Males

Parameter	HR [95% CI]	p-value
RHEUMA_SERONEG	1.235 [1.13, 1.35]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1862 out of 6759 males with RHEUMA_SERONEG died.

Mortality risk

Mortality risk for people of age

years, who have RHEUMA_SERONEG.

N-year risk	Females	Males
1	0.112%	0.21%
5	0.733%	1.35%
10	1.794%	3.447%
15	3.49%	6.677%
20	6.319%	11.123%

Relationships between endpoints

↥

Index endpoint: RHEUMA_SERONEG – Seronegative rheumatoid arthritis

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Seronegative rheumatoid arthritis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints